View All Upcoming Sponsored Webinars
Recorded February 24th, 2016
Join an expert panel of targeted therapy and laboratory data experts to learn about the “forgotten” but critical stakeholder in successful global targeted therapy launches, the molecular laboratory. Will you be launching a targeted therapy in the next 24-48 months? Then you won’t want to miss this unique event focused on global laboratory data and strategy when planning for a targeted therapy launch.
In his role as Managing Director of Labceutics, Ryan Keeling is instrumental in transforming the company’s vision for enabling the pharmaceutical industry to institutionalize personalized medicine planning into a software application. Ryan’s work on Diaceutics Fusion™ effortlessly transforms Diaceutics complex and data rich personalized medicine work tools and case studies into a software platform that allows for seamless integration and easy manipulation by Diaceutics clients. As the singular architect behind the Diaceutics Fusion™ platform, Ryan has created a software application that is at once completely customizable to clients' needs while at the same time being immediately hands-on and accessible to the industry.
Jordan Clark, PhD
Director Scientific Operations
Jordan has over 11-years' experience working in clinical laboratories, with particular expertise in hematology testing. Prior to joining Labceutics, Jordan worked in the Cambridge University Hospital's haemato-oncology diagnostic services and recently was a lead scientist for UK NEQAS, managing and developing their molecular EQA programmes.
Eloise Aita, PhD.
SVP US Laboratory Operations
Eloise Aita has more than 25 years of experience in the clinical laboratory industry working for independent, academic and hospital laboratories. She has been actively involved in all aspects of the laboratory industry and has extensive experience in the areas of lab management (Clinical and Anatomic Pathology), laboratory design, process improvement, cost containment, compliance and quality management.
EVP, Business Development
Mark has spent the past 17 years focused on healthcare business development and marketing at an international level within the pharmaceutical, biotechnology, healthcare informatics and personalized medicine industries. His previous positions at LumaSense Technologies, Inc., Philips Medical Systems, and Forbes Medi-tech, included wide-ranging responsibilities from marketing strategy and communications, sales operations and business development to investor relations and integrated marketing. Mark holds a Bachelor of Arts from the University of Western Ontario and an M.B.A from New York University Stern School of Business.
250 First Avenue, Suite 300
Needham, MA 02494
Biological Therapeutic Products
Biomarkers & Diagnostics
Bioprocess & Manufacturing
Clinical Trials & Translational Medicine
Drug & Device Safety
Drug Discovery & Development
IT & Informatics
Technology & Tools For Life Science
Cambridge Healthtech Institute
Cambridge Innovation Institute